CRIS Current Research Information System

BOLONDI, LUIGI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.682
EU - Europa 11.797
AS - Asia 6.355
AF - Africa 747
SA - Sud America 56
Continente sconosciuto - Info sul continente non disponibili 26
OC - Oceania 13
Totale 35.676
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.618
GB - Regno Unito 3.351
CN - Cina 2.147
VN - Vietnam 1.847
IT - Italia 1.618
DE - Germania 1.617
SE - Svezia 1.483
SG - Singapore 1.440
UA - Ucraina 785
RU - Federazione Russa 722
IN - India 619
IE - Irlanda 514
FR - Francia 475
ZA - Sudafrica 266
EE - Estonia 258
TG - Togo 256
FI - Finlandia 250
CH - Svizzera 241
BG - Bulgaria 137
JO - Giordania 126
CI - Costa d'Avorio 96
BE - Belgio 80
NG - Nigeria 66
CA - Canada 56
SC - Seychelles 54
NL - Olanda 52
IR - Iran 39
GR - Grecia 37
JP - Giappone 32
AT - Austria 30
HR - Croazia 30
RO - Romania 23
ES - Italia 21
EU - Europa 21
BR - Brasile 19
HK - Hong Kong 18
EC - Ecuador 16
LT - Lituania 16
ID - Indonesia 15
LB - Libano 14
PL - Polonia 14
CL - Cile 11
MK - Macedonia 9
AU - Australia 8
TR - Turchia 8
KR - Corea 7
UZ - Uzbekistan 7
MY - Malesia 6
A2 - ???statistics.table.value.countryCode.A2??? 5
CZ - Repubblica Ceca 5
NO - Norvegia 5
NZ - Nuova Zelanda 5
PE - Perù 5
AM - Armenia 4
BD - Bangladesh 4
DK - Danimarca 4
HU - Ungheria 4
IL - Israele 4
MX - Messico 4
MU - Mauritius 3
PT - Portogallo 3
SI - Slovenia 3
TW - Taiwan 3
AR - Argentina 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
LA - Repubblica Popolare Democratica del Laos 2
MM - Myanmar 2
PH - Filippine 2
PK - Pakistan 2
RS - Serbia 2
AL - Albania 1
AO - Angola 1
BY - Bielorussia 1
CG - Congo 1
CU - Cuba 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EG - Egitto 1
GA - Gabon 1
IQ - Iraq 1
KE - Kenya 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MA - Marocco 1
MD - Moldavia 1
NP - Nepal 1
PA - Panama 1
SA - Arabia Saudita 1
SM - San Marino 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 35.676
Salva come PNG Salva come JPEG
Città #
Southend 3.061
Fairfield 2.110
Chandler 1.501
Ashburn 1.304
Dong Ket 1.265
Singapore 1.242
Houston 1.005
Wilmington 989
Woodbridge 982
Seattle 883
Ann Arbor 731
Santa Clara 730
Cambridge 684
Princeton 676
Jacksonville 521
Dublin 513
Boardman 409
Westminster 312
Nanjing 305
Bologna 276
Padova 274
Lomé 256
Helsinki 237
Berlin 216
Bern 213
Munich 168
Saint Petersburg 159
Jinan 157
Shenyang 138
Sofia 137
Beijing 136
Amman 126
Nanchang 114
San Diego 108
Turin 103
Medford 99
Abidjan 96
Hebei 94
New York 94
Changsha 92
Milan 86
Mülheim 85
Brussels 79
Dearborn 75
Florence 68
Abeokuta 66
Tianjin 63
Shanghai 61
Zhengzhou 60
Guangzhou 59
Jiaxing 57
Bremen 50
Falls Church 50
Mahé 50
Ningbo 46
Redmond 46
Los Angeles 45
Norwalk 45
Des Moines 44
Olalla 44
Redwood City 43
Rome 39
Falkenstein 36
Phoenix 36
Yubileyny 36
Toronto 35
Haikou 34
Verona 33
Bühl 32
Mountain View 31
Hangzhou 30
London 29
Kunming 28
Taiyuan 28
Tokyo 27
Lanzhou 26
Frankfurt am Main 24
Taizhou 22
Hyderabad 21
Paris 21
Pune 21
Washington 21
Amsterdam 20
Vienna 19
Wuhan 19
Kuban 18
Nuremberg 17
Chicago 16
Fuzhou 16
Hong Kong 16
Moscow 15
Shijiazhuang 15
Ardabil 14
Columbus 14
Chengdu 13
Frankfurt Am Main 13
Hefei 13
Jakarta 13
San Venanzo 13
Harbin 12
Totale 24.624
Salva come PNG Salva come JPEG
Nome #
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 337
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 309
Molecular Adsorbent Recirculating System (MARS) application in liver failure: Clinical and hemodepurative results in 22 patients 268
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 236
A modeling study of bilirubin kinetics during Molecular Adsorbent Recirculating System sessions. 235
Impiego del MARS nell'insufficienza epatica: efficacia depurativa e risultati clinici in 22 pazienti 229
Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation 217
Differences in liver stiffness values obtained with new ultrasound elastography machines and Fibroscan: A comparative study 215
Accuracy of VirtualTouch Acoustic Radiation Force Impulse (ARFI) imaging for the diagnosis of cirrhosis during liver ultrasonography 209
Circulating microRNAs, MIR-939, MIR-595, MIR-519d and MIR-494, identify cirrhotic patients with HCC 208
A phase I study of continuous hepatic arterial infusion of Irinotecan in patients with locally advanced hepatocellular carcinoma. 198
A new priority policy for patients with hepatocellular carcinoma awaiting liver transplantation within the model for end-stage liver disease system. 195
Acute systemic, splanchnic and renal haemodynamic changes induced by molecular adsorbent recirculating system (MARS) treatment in patients with end-stage cirrhosis. 193
Adherence to AASLD guidelines for the treatment of hepatocellular carcinoma in clinical practice: experience of the Bologna Liver Oncology Group. 191
Laser ablation is superior to TACE in large-sized hepatocellular carcinoma: A pilot case-control study 191
Aberrant Notch3 and Notch4 expression in human hepatocellular carcinoma. 184
Evaluation of the impact of transient interruption of antiangiogenic treatment using ultrasound-based techniques in a murine model of hepatocellular carcinoma 179
Clinical Impact and Safety of Anticoagulants for Portal Vein Thrombosis in Cirrhosis 177
Ablazione percutanea ecoguidata mediante radiofrequenza di piccoli noduli di HCC: fattori correlati all'esito clinico e alla recidiva di malattia 172
A new mathematical model for bilirubin kinetics during MARS sessions 167
Application of the Intermediate-Stage Subclassification to Patients with Untreated Hepatocellular Carcinoma 167
null 164
Platelet count does not predict bleeding in cirrhotic patients: Results from the PRO-LIVER Study 164
Analysis of risk factors for tumor recurrence after liver transplantation for hepatocellular carcinoma: key role of immunosuppression. 163
Nozioni di ecografia Doppler e color-Doppler 157
Use of perfusional angiosonography in liver transplantation and conservative management of post-transplant intra-hepatic pseudo-aneurysm. 156
Linee guida A.I.S.F. per l'ipertensione portale. 154
Artificial neural network is superior to MELD in predicting mortality of patients with end-stage liver disease. 154
Assessment of liver fibrosis in trnsplant recipients with recurrent HCV infection: Usefulness of transient elastography. 153
Analysis of risk factors for early hepatic artery thrombosis after liver transplantation. Possible contribution of reperfusion in the early morning. 152
LncRNAs as novel players in hepatocellular carcinoma recurrence 152
Corrigendum: Vidatox 30 CH has tumor activating effect in hepatocellular carcinoma (Scientific Reports (2017) 7 (44685) DOI: 10.1038/srep44685) 150
Affidabilità della combinazione di angioecografia perfusionale ed altre tecniche di imaging nella valutazione della trombosi portale in pazienti con epatocarcinoma (HCC) candidati al trapianto di fegato 150
Comparison between alcohol- and hepatitis C virus-related hepatocellular carcinoma: clinical presentation, treatments and outcome. 149
Curative therapies are superior to standard of care (transarterial chemoembolization) for intermediate stage hepatocellular carcinoma. 149
CDKN1C/P57 Is Regulated by the Notch Target Gene Hes1 and Induces Senescence in Human Hepatocellular Carcinoma. 148
Reliability of imaging techniques in assessing portal venous thrombosis in patients with hepatocellular carcinoma candidates for liver transplantation 148
Usefulness of contrast-enhanced perfusional sonography in the assessment of hepatocellular carcinoma hypervascular at spiral computed tomography. 147
Development and Validation of a New Prognostic System for Patients with Hepatocellular Carcinoma 147
Binding of the doxorubicin-lactosaminated human albumin conjugate to HCC cells is mediated by the drug moieties. 147
ASSOCIATIONS OF THE -174 G/C INTERLEUKIN-6 GENE PROMOTER POLYMORPHISM WITH SERUM INTERLEUKIN -6 AND MORTALITY IN THE ELDERLY 146
Correlation between LDH levels and response to sorafenib in HCC patients: an analysis of the ITA.LI.CA. database 146
A case of inflammatory ascites. 146
Characterization of primary and recurrent nodules in liver cirrhosis using contrast-enhanced ultrasound: which vascular criteria should be adopted? 145
Comparison of International Guidelines for Noninvasive Diagnosis of Hepatocellular Carcinoma 144
Conditional survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients. 144
Current guidelines for the management of non-alcoholic fatty liver disease: A systematic review with comparative analysis 144
Cost analysis of recall strategies for non-invasive diagnosis of small hepatocellular carcinoma. 144
Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. 143
Contrast-enhanced ultrasonography features of extramedullary hematopoiesis presenting as a presacral mass: an update of the literature. 143
Characterization of focal liver lesions with contrast-enhanced ultrasound. 143
Extracorporeal Detoxification for Hepatic Failure Using Molecular Adsorbent Recirculating System: Depurative Efficiency and Clinical Results in a Long-Term Follow-Up 143
A case of intractable pruritus in Turner's syndrome successfully treated with molecular adsorbent recirculating system. 142
Efficacy of doxorubicin coupled to lactosaminated albumin on rat hepatocellular carcinomas evaluated by ultrasound imaging. 141
Celiac disease diagnosed through screening programs in at-risk adults is not associated with worse adherence to the gluten-free diet and might protect from osteopenia/osteoporosis 141
Enhanced uptake of lactosaminated human albumin by rat hepatocarcinomas: implications for an improved chemotherapy of primary liver tumors. 140
Contrast-enhanced ultrasonography to diagnose complicated acute cholecystitis 139
Immune inflammation indicators and ALBI score to predict liver cancer in HCV-patients treated with direct-acting antivirals 139
In hepatocellular carcinoma miR-221 modulates sorafenib resistance through inhibition of caspase-3–mediated apoptosis 138
Doxorubicin coupled to lactosaminated albumin: effect of heterogeneity in drug load on conjugate disposition and hepatocellular carcinoma uptake in rats. 137
Doxorubicin coupled to lactosaminated human albumin: a hepatocellular carcinoma targeted drug. 137
Quantification of enhancement of focal liver lesions during contrast-enhanced ultrasound (CEUS). Analysis of ten selected frames is more simple but as reliable as the analysis of the entire loop for most parameters. 137
A conjugate of doxorubicin with lactosaminated albumin enhances the drug concentrations in all the forms of rat hepatocellular carcinomas independently of their differentation grade. 137
Diagnostic features of real-time contrast-enhanced ultrasound in focal nodular hyperplasia of the liver. 136
Cholangiocarcinoma in Cirrhosis: Value of Hepatocyte Specific Magnetic Resonance Imaging 136
F.N.27 NOTCH SIGNALLING CONTROLS PROLIFERATION AND SENESCENCE OF HUMAN HEPATOCELLULAR CARCINOMA 135
Clinical impact of ultrasound-related techniques on the diagnosis of focal liver lesions 135
Long term follow-up and outcome of liver transplantation for alcoholic liver disease: a single center case-control study 135
Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinoma for liver transplantation. 135
Clinical and diagnostic aspects of gluten related disorders 134
Comparison of recurrence of hepatocellular carcinoma after resection in patients with cirrhosis to its occurrence in a surveilled cirrhotic population. 133
Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma. 133
Venom from Cuban Blue Scorpion has tumor activating effect in hepatocellular carcinoma 133
The rational use of albumin in patients with cirrhosis and ascites. A Delphi study for the attainment of a consensus on prescribing standards. 132
Impiego clinico del “Fegato Artificiale” MARS: effetti sulle citochine e sui fattori di crescita 132
Thorough assessment of portal venous thrombosis in patients with HCC allows adequate selection of candidates for liver transplantation 132
Brain and kidney, victims of atrial microembolism in elderly hospitalized patients? Data from the REPOSI study. 131
A relative deficiency of lysosomal acid lypase activity characterizes non-alcoholic fatty liver disease 131
Clinical and economical impact of 2010 AASLD guidelines for the diagnosis of hepatocellular carcinoma 131
Real time contrast enhanced ultrasonography in detection of liver metastases from gastrointestinal cancer 130
Oncogenic role of miR-483-3p at the IGF2/483 locus. 130
Imbalance of Neutrophils and Lymphocyte Counts Can Be Predictive of Hepatocellular Carcinoma Occurrence in Hepatitis C-related Cirrhosis Treated With Direct-acting Antivirals 130
Clinical application of artificial liver support with the Molecular Adsorbent Recirculating System (MARS): impact on cytokines and growth factors 130
Impact of gadoxetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance on the non-invasive diagnosis of small hepatocellular carcinoma: a prospective study 129
Molecular and proteomic insight into Notch1 characterization in hepatocellular carcinoma 129
Caution in the use of boldo in herbal laxatives: a case of hepatotoxicity. 128
Targeting notch3 in hepatocellular carcinoma: Molecular mechanisms and therapeutic perspectives 127
Increased risk of nonalcoholic fatty liver disease in patients with coeliac disease on a gluten-free diet: beyond traditional metabolic factors 126
MiR-30e-3p influences tumor phenotype through MDM2/TP53 axis and predicts sorafenib resistance in hepatocellular carcinoma 126
MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality. 125
L'albumina 60 anni dopo: evidenze e prospettive. Dalla fisiologia alla clinica. 124
Role of Real-Time Contrast-Enhanced Ultrasound in the Assessment of Metastatic Portal Vein Thrombosis. 124
Characterization of Small Nodules (1-3 cm) in Cirrhosis. The role of Perfusional Angiosonography, Spiral Computed Tomography and Double Contrast Magnetic Resonance 124
The epigenetically regulated miR-494 associates with stem-cell phenotype and induces sorafenib resistance in hepatocellular carcinoma 124
Corrigendum to “Differences in liver stiffness values obtained with new ultrasound elastography machines and fibroscan: A comparative study” [Dig. Liver Dis. 49 (2017) 802–808](S1590865817302463)(10.1016/j.dld.2017.03.001) 124
Doxorubicin coupled to lactosaminated albumin inhibits the growth of hepatocellular carcinomas induced in rats by diethylnitrosamine. 123
Pharmaceutical composition and pharmaceutical kit for the treatment oh hepatocellular carcinoma 122
Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): A phase 3, randomised, double-blind, placebo-controlled trial 122
Facing the enigma of the vascular network in hepatocellular carcinomas in cirrhotic and non-cirrhotic livers. 122
Partial necrosis on hepatocellular carcinoma nodules facilitates tumor recurrence after liver transplantation. 121
Totale 15.414
Salva come PNG Salva come JPEG
Categoria #
all - tutte 94.854
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 94.854
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.554 0 0 0 0 0 0 0 0 1.149 587 332 486
2020/20215.062 961 306 150 191 83 276 124 250 394 282 220 1.825
2021/20226.466 775 251 385 523 573 373 153 376 206 370 1.505 976
2022/20236.532 742 918 314 838 411 483 175 314 1.176 170 535 456
2023/20241.653 139 292 111 167 145 366 87 85 72 94 52 43
2024/20254.755 266 1.124 564 497 1.108 367 520 236 73 0 0 0
Totale 36.446